Tag: Ultragenyx Pharmaceutical Inc.

Stock Earnings

Ultragenyx Pharmaceutical Inc [RARE] Shares Jump Approximately 37.95% Over the Year

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

A company insider recently sold 7,465 shares of Ultragenyx Pharmaceutical Inc [RARE]. Should You also Consider to Sale?

In a filing, Ultragenyx Pharmaceutical Inc revealed its Chief Financial Officer Horn Howard unloaded Company’s shares for reported $0.39 million

Stock Earnings

Goldman Upgrades Ultragenyx Pharmaceutical Inc (RARE) to a Buy from a Neutral

Ultragenyx Pharmaceutical Inc’s recent filing unveils that its Chief Financial Officer Horn Howard unloaded Company’s shares for reported $0.39 million

Insiders Updates

Taking a look at what insiders are doing to gauge the Ultragenyx Pharmaceutical Inc (RARE)’s direction

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Ultragenyx Pharmaceutical Inc. [RARE] Horn Howard sells 7,465 Shares for $0.39 million

Ultragenyx Pharmaceutical Inc.’s recently made public that its Chief Financial Officer Horn Howard unloaded Company’s shares for reported $0.39 million

Stock Earnings

Ultragenyx Pharmaceutical Inc. [RARE] Records 50-Day SMA of $55.87

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Selling Buzz: Ultragenyx Pharmaceutical Inc. [RARE] Chief Financial Officer Horn Howard sells 7,465 shares of the company

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Ultragenyx Pharmaceutical Inc. (RARE) may enjoy gains as insiders got busy in the recent days

Ultragenyx Pharmaceutical Inc.’s filing revealed that its Chief Financial Officer Horn Howard unloaded Company’s shares for reported $0.39 million on

Insiders Updates

Insider Selling: KAKKIS EMIL D, Ultragenyx Pharmaceutical Inc. [RARE] President & CEO divested 20,000 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ultragenyx Pharmaceutical

Analysts Viewpoint

Taking a Closer Look At Ultragenyx Pharmaceutical Inc. (RARE) Following Its Recent Trade

Ultragenyx Pharmaceutical Inc.’s recent filing unveils that its President & CEO KAKKIS EMIL D unloaded Company’s shares for reported $1.12